| 47.885 0.969 (2.07%) | 10-02 15:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 56.41 |
1-year : | 65.89 |
| Resists | First : | 48.29 |
Second : | 56.41 |
| Pivot price | 46.78 |
|||
| Supports | First : | 46.89 |
Second : | 46.02 |
| MAs | MA(5) : | 46.73 |
MA(20) : | 46.96 |
| MA(100) : | 48.64  |
MA(250) : | 44.53 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 60.5 |
D(3) : | 36.3 |
| RSI | RSI(14): 56.2 |
|||
| 52-week | High : | 52.81 | Low : | 36.81 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CBSE ] has closed It is unclear right now based on current values. 46.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 48.05 - 48.22 | 48.22 - 48.38 |
| Low: | 46.9 - 47.12 | 47.12 - 47.32 |
| Close: | 47.54 - 47.84 | 47.84 - 48.12 |
The fund's objective is to closely mirror the investment performance of the Bloomberg World All-Cap Equal Weight TR Index.
Thu, 09 Jul 2026
SMArtX Advisory Solutions Expands Manager Marketplace with Investment Strategies from 27 Leading Asset Management Firms - PR Newswire
Wed, 20 May 2026
ImmunityBio Stock Climbs As FDA Accepts Expanded Use Filing For Bladder Cancer Drug - Benzinga
Tue, 21 Apr 2026
Clough Capital’s Actively Managed ETF Platform Surpasses $100 Million in Assets Under Management - Business Wire
Thu, 02 Apr 2026
Clough Select Equity ETF (NYSE: CBSE) Share Price, CBSE Stock News, CBSE Share Price & Updates - kalkine.ca
Mon, 15 Dec 2025
Clough Capital Appoints Brett Tracy as Portfolio Specialist - Business Wire
Tue, 09 Jan 2024
Share Investing | Share Prices, Performance & Recommendations - intelligentinvestor.com.au
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management - Bonds
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|